5% MONTHLY HOLDINGS REPORT

Company

VERTEX PHARMACEUTICALS INC / MA

Filed

March 9, 1998

Accession Number

0000766524-98-000455

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →